Newwill Biotech Private Limited
About Newwill Biotech Private Limited
Data last updated:
Newwill Biotech Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 30 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2010PTC055001. Its GSTIN is 29AADCN5621J1ZA (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Nuwill Biotech Private Limited. It is led by directors including Vibha Sarika Reddy and Cattamanchi Bavya Latha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – A1 Ground Floor 7th Cross 27th Main Sector 1 Hsr Layout, Bangalore, Karnataka, India – 560102.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.1 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹12.26 Lakh (net margin 5.8%) and EBITDA of ₹20.85 Lakh (EBITDA margin 9.9%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 5% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1 – A1 Ground Floor 7th Cross 27th Main Sector 1 Hsr Layout, Bangalore, Karnataka, India – 560102
- IndustryHealthcare, Medical Consumables & Supplies
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Newwill Biotech Private Limited
The main business activity of Newwill Biotech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Newwill Biotech Private Limited FY 2025 filings available
Newwill Biotech Private Limited reported revenue of ₹2.1 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Newwill Biotech Private Limited
Revenue rose 13% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Newwill Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹20.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.26 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Newwill Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Newwill Biotech are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Newwill Biotech Private Limited
Newwill Biotech Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arizzer Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Dr Dubri Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2021) | •••• | •••• | -31.0% | •••• | New Delhi, Delhi, India |
| Krish Surgical Pvt Ltd | ₹2.11 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Haryana, India |
| Jupiven Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Delhi, India |
| Aeclat Lifesciences Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Ahmedabad, Gujarat, India |
| Newwill Biotech Private Limited this company | ₹2.1 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Bangalore, Karnataka, India |
| K Square Life Sciences Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Gaziabad, Uttar Pradesh, India |
| Yotta Business Ventures Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ajmer, Rajasthan, India |
| Mihir Synthetics Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Pharma Corner Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Hathras, Uttar Pradesh, India |
| Gemshi Pharmaceuticals Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 143.0% | •••• | Ulhasnagar, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Newwill Biotech by revenue in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Newwill Biotech Private Limited
Newwill Biotech Private Limited is audited by RAMESH ASHWIN & KARANTH for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAMESH ASHWIN & KARANTH | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Newwill Biotech Private Limited
Newwill Biotech has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vibha Sarika Reddy | Director | 20 Sep 2019 | 7 Years 0 Months | Current |
| Cattamanchi Bavya Latha | Director | 28 Jan 2011 | 15 Years 8 Months | Current |
| Hemashree Gunjuru | Director | 06 May 2015 | 11 Years 5 Months | Current |
Ownership and Shareholding of Newwill Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Newwill Biotech Private Limited
Newwill Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Newwill Biotech Private Limited
Newwill Biotech Private Limited has a workforce of 6 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Newwill Biotech Private Limited
Newwill Biotech Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Vibha Sarika Reddy was appointed as Director on 20 Sep 2019.
Credit Ratings, Litigation & Regulatory Alerts for Newwill Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Newwill Biotech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Newwill Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Newwill Biotech Private Limited
Newwill Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCN5621J1ZA | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Newwill Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Newwill Biotech Private Limited
Newwill Biotech is an active private limited company based in Bangalore, Karnataka, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 30 August 2010 (16+ years old) and is registered under CIN U51909KA2010PTC055001.
Newwill Biotech reported revenue of ₹2.1 Cr for FY 2025 (up 13% YoY).
Newwill Biotech has 3 current directors:
- Vibha Sarika Reddy - Director
- Cattamanchi Bavya Latha - Director
- Hemashree Gunjuru - Director
Newwill Biotech reported a net profit of ₹12.26 Lakh (net margin 5.8%) and EBITDA of ₹20.85 Lakh (EBITDA margin 9.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Newwill Biotech is -8% over three years and -5% over five years. In the latest year (FY 2025) revenue rose 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Newwill Biotech is 29AADCN5621J1ZA, registered in Karnataka.
The CIN (Corporate Identification Number) of Newwill Biotech is U51909KA2010PTC055001. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Newwill Biotech was incorporated on 30 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Newwill Biotech by revenue are Arizzer Pharmaceuticals Private Limited, Dr Dubri Pharmaceuticals Private Limited, Krish Surgical Pvt Ltd, Jupiven Pharmaceuticals Private Limited, Aeclat Lifesciences Private Limited and 5 more, all in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution).
Vibha Sarika Reddy was appointed as Director on 20 Sep 2019. Gunjur Ramaiah Reddy Jayanagaraja Reddy ceased to be Director on 01 Mar 2018. Hemashree Gunjuru was appointed as Director on 06 May 2015. Newwill Biotech has 5 board changes on record in total.
The registered office of Newwill Biotech is at 1 – A1 Ground Floor 7th Cross 27th Main Sector 1 Hsr Layout, Bangalore, Karnataka, India – 560102.